RxDoctor Payments Data

Don Scicchitano

Physician Assistant · Sun City West, AZNPI 1902034648

Payments from drug & device makers

$1,053in general payments, 2019–2025

Across 27 payments — averaging $38.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$479
  • GSK$214
  • Mylan Specialty L.p.$125
  • Philips North America LLC$57
  • ZOLL Respicardia, Inc.$56
  • Sanofi$55
  • plus $67 from 3 others

What the payments were for

  • Food & beverage$1,03098%
  • Education$232%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,053 in reported general payments places this provider in the 70th percentile of 2,888 physician assistant providers in Arizona.

See all physician assistant providers in Arizona

Medicare billing

Part B allowed, 2024
$5,878
Medicare patients
50
Services billed
73

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter138$132,086
GlassiaAlpha-1-Proteinase Inhibitor11$126,656
Spiriva RespimatTiotropium Bromide50$50,075
Breo ElliptaFluticasone/Vilanterol60$37,144
Breztri AerosphereBudesonide/Glycopyr/Formoterol36$30,743
Fluticasone-SalmeterolFluticasone Propion/Salmeterol82$17,859
Stiolto RespimatTiotropium Br/Olodaterol Hcl14$12,470
Wixela InhubFluticasone Propion/Salmeterol48$10,913
Albuterol Sulfate HfaAlbuterol Sulfate274$9,384
SymbicortBudesonide/Formoterol Fumarate15$9,091
Fluconazole53$4,542
CefuroximeCefuroxime Axetil106$1,588
Azelastine Hcl60$1,491
Ventolin HfaAlbuterol Sulfate14$1,468
Montelukast Sodium119$1,215

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta$214$169,230198 claims
Boehringer IngelheimSpiriva Respimat, Stiolto Respimat$32$62,54564 claims
AstraZenecaBreztri Aerosphere, Symbicort$479$39,83451 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,888 physician assistant providers in Arizona.

Other physician assistant in Sun City West

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →